Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pediatr. 2003 Nov;143(5):674-7.

Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report.

Author information

1
Department of Pediatrics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. wylam.mark@mayo.edu

Abstract

We report the successful use of anti-CD20 therapy in a child with refractory myasthenia gravis (MG), an antibody-mediated autoimmune disease, who did not respond to conventional therapy. After initiation of anti-CD20 therapy, clinical improvement (muscular strength, pulmonary function) was observed.

PMID:
14615745
DOI:
10.1067/S0022-3476(03)00300-7
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center